MKO Troche Alternatives Compared
| MKO Troche (ketamine / midazolam / ondansetron) | Vigamox (moxifloxacin) | Ofloxacin ophthalmic |
|
|---|
| MKO Troche (ketamine / midazolam / ondansetron) | Vigamox (moxifloxacin) | Ofloxacin ophthalmic |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Ophthalmic Surgery. MKO Troche may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Conjunctivitis - Bacterial, Ophthalmic Surgery. Vigamox may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Corneal Ulcer, Ophthalmic Surgery, Conjunctivitis - Bacterial. Ofloxacin ophthalmic may also be used for purposes not listed in this medication guide. |
Related suggestions Ophthalmic Surgery
|
|||||||||||||||
| More about Vigamox (moxifloxacin) | More about Ofloxacin ophthalmic | |||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Vigamox has an average rating of 5.5 out of 10 from a total of 17 ratings on Drugs.com. 41% of reviewers reported a positive effect, while 47% reported a negative effect. |
Ofloxacin ophthalmic has an average rating of 6.5 out of 10 from a total of 6 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Vigamox side effects |
View all Ofloxacin ophthalmic side effects |
|||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Vigamox prices |
View all Ofloxacin ophthalmic prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other ketamine / midazolam / ondansetron brands include: MKO Melt Dose Pack | Other moxifloxacin brands include: Moxeza | Ocuflox | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
4 hours |
13 hours |
N/A |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 807 drugs are known to interact with MKO Troche:
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
April 15, 2003 |
N/A |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.